Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
暂无分享，去创建一个
S. Servaes | A. Naranjo | J. Maris | S. Asgharzadeh | W. London | M. Diccianni | A. Yu | H. Katzenstein | B. Shulkin | M. Parisi | R. Bagatell | Julie R. Park | J. Hank | P. Sondel | R. Mody | Jen Birstler | M. Felder | J. Glade-Bender | Fan F Zhang | J. Birstler | Sabah E. Servaes | Julia L. Glade-Bender | Fan F. Zhang | Sabah Servaes